Cardiff Oncology, Inc.
CRDF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$45 | -$41 | -$39 | -$28 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $1 |
| Stock-Based Comp. | $5 | $5 | $4 | $3 |
| Change in WC | $3 | $7 | -$0 | -$2 |
| Other Non-Cash | -$1 | -$1 | $1 | $2 |
| Operating Cash Flow | -$38 | -$31 | -$34 | -$23 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | -$0 | $0 |
| Inv. Purchases | -$24 | -$70 | -$91 | -$174 |
| Inv. Sales/Matur. | $37 | $107 | $130 | $43 |
| Other Inv. Act. | $0 | $0 | $0 | -$0 |
| Investing Cash Flow | $14 | $36 | $38 | -$131 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $53 | $0 | $0 | $34 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | -$0 | -$0 |
| Other Fin. Act. | $0 | $0 | $0 | $1 |
| Financing Cash Flow | $54 | $0 | $0 | $35 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $30 | $5 | $4 | -$119 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22 | $16 | $12 | $131 |
| End Cash | $51 | $22 | $16 | $12 |
| Free Cash Flow | -$38 | -$31 | -$35 | -$23 |